Navigation Links
Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
Date:10/18/2007

First FDA-Approved Artificial Disc For The Cervical Spine Now Available In

Texas

TYLER, Texas, Oct. 18 /PRNewswire/ -- Sabatino Bianco, MD, Trinity Clinic Neurosurgeon and Director of the Trinity Mother Frances Neuroscience Institute is the first in the region to offer a new FDA approved cervical arthroplasty implant that can provide some patients a chance to maintain motion in their necks following surgery for cervical degenerative disc disease.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061117/DAF023LOGO)

To view the Multimedia News Release, go to:

http://www.prnewswire.com/mnr/tmfneuroscience/30242/

The new artificial disc, called the PRESTIGE(R) Cervical Disc, is the first artificial disc approved for the cervical spine by the U.S. Food and Drug Administration.

The disc is inserted into the neck using a similar procedure to the technique surgeons use when performing a spinal fusion and is used in a procedure called cervical disc arthroplasty. The new procedure showed superior neurological and overall success outcomes in a recently concluded clinical trial that compared the clinical outcomes of cervical artificial disc replacement (PRESTIGE Cervical Disc) to anterior cervical discectomy and spinal fusion procedures.

"The Prestige Cervical Disc is an exciting new option for my patients," said Dr. Bianco. "This disc may revolutionize treatment options for surgical patients who normally would have only the option of a motion-restricting process of spinal fusion."

In the U.S. clinical trial of the PRESTIGE Cervical disc, patients who received the disc showed improved neurological success at 24 months and improved overall success. The clinical trial is the largest, completed, prospective randomized controlled study of its kind in the cervical spine enrolling a total of 541 patients.

Trinity Mother Frances Health System is comprised of Mother Frances Hospital-Tyler, Mother Frances Hospital-Jacksonville, Trinity Mother Frances Rehabilitation Hospital (affiliated with HealthSouth) and Trinity Clinic, a multi-specialty physician group. The Health System treats patients in many medical specialties, including neurosurgery and robotic-assisted heart procedures.

For more information on the PRESTIGE Cervical disc procedure available at the Trinity Mother Frances Neuroscience Institute, call (903) 525-7995 or visit http://www.tmfneuroscience.com.


'/>"/>
SOURCE Trinity Mother Frances Neuroscience Institute
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. A disgusting video: U.S. companies sell out Americans
2. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
3. TomoTherapy opens technical training center
4. TomoTherapy raises $223 million in IPO
5. TomoTherapy revises IPO money target
6. Hospital named for Madame Curie installs TomoTherapy system
7. TomoTherapy files registration statement for IPO
8. TomoTherapy to sell medical devices in India
9. TomoTherapy sees sustained market advantage
10. TomoTherapys 100th radiology system reaches public sector
11. TomoTherapy extends reach to Germany
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):